{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:05:18Z","timestamp":1792591518986,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.yebeh.2025.110660","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T17:45:15Z","timestamp":1756403115000},"page":"110660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Efficacy, safety and tolerability of adjunctive cenobamate in pediatric and adult patients with Lennox Gastaut Syndrome"],"prefix":"10.1016","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1349-3409","authenticated-orcid":false,"given":"A.W.","family":"Pong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wehland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.yebeh.2025.110660_b0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/epi.12567","article-title":"Lennox-Gastaut syndrome: a consensus approach to differential diagnosis","volume":"55","author":"Bourgeois","year":"2014","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110660_b0010","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/08830738211000514","article-title":"Evolution of Infantile Spasms to Lennox-Gastaut Syndrome: what is there to know?","volume":"36","author":"Nelson","year":"2021","journal-title":"J Child Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110660_b0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/14737175.2024.2323568","article-title":"Diagnosis of Lennox-Gastaut syndrome and strategies for early recognition","volume":"24","author":"Pujar","year":"2024","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110660_b0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/mrdd.20029","article-title":"Lennox-Gastaut syndrome: potential mechanisms of cognitive regression","volume":"10","author":"Blume","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"10.1016\/j.yebeh.2025.110660_b0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-2000-7456","article-title":"Nonconvulsive status epilepticus\u2013a possible cause of mental retardation in patients with Lennox-Gastaut syndrome","volume":"31","author":"Hoffmann-Riem","year":"2000","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2025.110660_b0030","doi-asserted-by":"crossref","unstructured":"Knowles JK, Warren AEL, Mohamed IS, Stafstrom CE, Koh HY, Samanta D, Shellhaas RA, Gupta G, Dixon-Salazar T, Tran L, Bhatia S, McCabe JM, Patel AD, Grinspan ZM. Clinical trials for Lennox-Gastaut syndrome: Challenges and priorities. Ann Clin Transl Neurol. 2024 Nov;11(11):2818-2835. doi: 10.1002\/acn3.52211. Epub 2024 Oct 23. PMID: 39440617; PMCID: PMC11572735.","DOI":"10.1002\/acn3.52211"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110660_b0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM199301073280105","article-title":"Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome)","volume":"328","author":"Felbamate Study Group in Lennox-Gastaut Syndrome","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2025.110660_b0040","doi-asserted-by":"crossref","unstructured":"Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med. 1997 Dec 18;337(25):1807-12. doi: 10.1056\/NEJM199712183372504. Erratum in: N Engl J Med 1998 Sep 17;339(12):851-2. PMID: 9400037.","DOI":"10.1056\/NEJM199712183372504"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110660_b0045","first-page":"1882","article-title":"A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome","volume":"52","author":"Sachdeo","year":"1999","journal-title":"Topiramate YL Study Group Neurology"},{"issue":"21","key":"10.1016\/j.yebeh.2025.110660_b0050","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","article-title":"Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome","volume":"70","author":"Glauser","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2025.110660_b0055","doi-asserted-by":"crossref","unstructured":"Ng YT, Conry JA, Drummond R, Stolle J, Weinberg MA; OV-1012 Study Investigators. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology. 2011 Oct 11;77(15):1473-81. doi: 10.1212\/WNL.0b013e318232de76. Epub 2011 Sep 28. PMID: 21956725.","DOI":"10.1212\/WNL.0b013e318232de76"},{"issue":"8","key":"10.1016\/j.yebeh.2025.110660_b0060","first-page":"795","article-title":"Cannabidiol in the Lennox-Gastaut Syndrome","volume":"379","author":"Devinsky","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110660_b0065","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jamaneurol.2022.0829","article-title":"Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated with Lennox-Gastaut Syndrome: a Randomized Clinical Trial","volume":"79","author":"Knupp","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2025.110660_b0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.seizure.2018.10.016","article-title":"The pharmacological management of Lennox-Gastaut syndrome and critical literature review","volume":"63","author":"Verrotti","year":"2018","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110660_b0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/WCO.0000000000001144","article-title":"Recent advances in pharmacotherapy for epilepsy","volume":"36","author":"Pong","year":"2023","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110660_b0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/jcm12010129","article-title":"Treatment with Cenobamate in Adult patients with Lennox-Gastaut Syndrome: a Case Series","volume":"12","author":"Falcicchio","year":"2022","journal-title":"J Clin Med"},{"issue":"14","key":"10.1016\/j.yebeh.2025.110660_b0085","article-title":"Cenobamate significantly improves seizure control in intellectually disabled patients with drug-resistant epilepsy and allows drug load reduction","volume":"17","author":"Friedo","year":"2023","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2025.110660_b0090","doi-asserted-by":"crossref","unstructured":"Buhleier E, Schubert-Bast S, Knake S, von Podewils F, Hamer HM, Melzer N, Kurlemann G, Klotz KA, Willems LM, Rosenow F, Brunklaus A, Strzelczyk A. A multicenter cohort study on the efficacy, retention, and tolerability of cenobamate in patients with developmental and epileptic encephalopathies. Epilepsia. 2025 May;66(5):1519-1528. doi: 10.1111\/epi.18308. Epub 2025 Feb 11. PMID: 39932331; PMCID: PMC12097476.","DOI":"10.1111\/epi.18308"},{"key":"10.1016\/j.yebeh.2025.110660_b0095","doi-asserted-by":"crossref","unstructured":"Brodie MJ, Barry SJ, Bamagous GA, Norrie JD, Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology. 2012 May 15;78(20):1548-54. doi: 10.1212\/WNL.0b013e3182563b19. Epub 2012 May 9. PMID: 22573629; PMCID: PMC3348850.","DOI":"10.1212\/WNL.0b013e3182563b19"},{"key":"10.1016\/j.yebeh.2025.110660_b0100","author":"Information"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110660_b0105","first-page":"609","article-title":"Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics","volume":"35","author":"Roberti","year":"2021","journal-title":"Drug-Drug Interactions and Tolerability CNS Drugs"},{"key":"10.1016\/j.yebeh.2025.110660_b0110","doi-asserted-by":"crossref","unstructured":"Smith MC, Klein P, Krauss GL, Rashid S, Seiden LG, Stern JM, Rosenfeld WE. Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations. Neurol Ther. 2022 Dec;11(4):1705-1720. doi: 10.1007\/s40120-022-00400-5. Epub 2022 Sep 3. PMID: 36057761; PMCID: PMC9588096.","DOI":"10.1007\/s40120-022-00400-5"},{"key":"10.1016\/j.yebeh.2025.110660_b0115","doi-asserted-by":"crossref","unstructured":"Krauss GL, Klein P, Brandt C, Lee SK, Milanov I, Milovanovic M, Steinhoff BJ, Kamin M. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial. Lancet Neurol. 2020 Jan;19(1):38-48. doi: 10.1016\/S1474-4422(19)30399-0. Epub 2019 Nov 14. Erratum in: Lancet Neurol. 2020 Mar;19(3):e3. doi: 10.1016\/S1474-4422(20)30038-7. PMID: 31734103.","DOI":"10.1016\/S1474-4422(19)30399-0"},{"key":"10.1016\/j.yebeh.2025.110660_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2022.106952","article-title":"Efficacy of cenobamate for uncontrolled focal seizures in patients with previous epilepsy-related surgery: Post hoc analysis of a phase 3, multicenter, open-label study","volume":"184","author":"Abou-Khalil","year":"2022","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2025.110660_b0125","doi-asserted-by":"crossref","unstructured":"Strzelczyk A, Schubert-Bast S. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies. CNS Drugs. 2022 Oct;36(10):1079-1111. doi: 10.1007\/s40263-022-00955-9. Epub 2022 Oct 4. PMID: 36194365; PMCID: PMC9531646.","DOI":"10.1007\/s40263-022-00955-9"},{"key":"10.1016\/j.yebeh.2025.110660_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2022.107028","article-title":"EEG parameters as endpoints in epilepsy clinical trials - an expert panel opinion paper","volume":"187","author":"Buchhalter","year":"2022","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2025.110660_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106459","article-title":"Drug-drug interactions and pharmacodynamics of concomitant clobazam and cannabidiol or stiripentol in refractory seizures","volume":"99","author":"Klein","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110660_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109156","article-title":"The cenobamate-clobazam interaction- evidence of synergy in addition to pharmacokinetic interaction","volume":"142","author":"Osborn","year":"2023","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025004007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505025004007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:35:22Z","timestamp":1780299322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505025004007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"alternative-id":["S1525505025004007"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110660","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety and tolerability of adjunctive cenobamate in pediatric and adult patients with Lennox Gastaut Syndrome","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110660"}}